Immune response to influenza vaccination

Granulomatous peritoneal disease associated with oxaliplatin-based chemotherapy for ampullary adenocarcinoma: a case report.

Acta gastro-enterologica Belgica·2023

The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF vaccination in EGFR-mutant metastatic NSCLC.

Lung cancer (Amsterdam, Netherlands)·2021

Cell disruption for microalgae biorefineries.

Biotechnology advances·2015

A longitudinal analysis of gross motor coordination in overweight and obese children versus normal-weight peers.

International journal of obesity (2005)·2012

Cross-protection against homologous drift variants of influenza A and B after vaccination with split vaccine.

Intervirology·2006

GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing.

Oncogene·2005

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Relationship Between Comprehensive Inflammatory Indicators and Gout Risk: A Cross-sectional Study Based on NHANES 2015-2018.

Endocrine, metabolic & immune disorders drug targets·2026

Serological Remission Defined by Anti-Integrin αvβ6 Antibody Predicts Long-Term Clinical Remission of Ulcerative Colitis.

Gastro hep advances·2026

Heterogeneity in semen-mediated tolerogenic responses: defining immunological determinants of reproductive compatibility.

Human reproduction open·2026

Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty.

Frontiers in immunology·2026

Immune checkpoint inhibitors in HIV infection: current evidence on viral reservoir regulation and immune restoration.

Frontiers in immunology·2026

Correction: Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty.

Frontiers in immunology·2026

Related Experiment Videos

Immune response to influenza vaccination

Related Concept Videos

Granulomatous peritoneal disease associated with oxaliplatin-based chemotherapy for ampullary adenocarcinoma: a case report.

The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF vaccination in EGFR-mutant metastatic NSCLC.

Cell disruption for microalgae biorefineries.

A longitudinal analysis of gross motor coordination in overweight and obese children versus normal-weight peers.

Cross-protection against homologous drift variants of influenza A and B after vaccination with split vaccine.

GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Relationship Between Comprehensive Inflammatory Indicators and Gout Risk: A Cross-sectional Study Based on NHANES 2015-2018.

Serological Remission Defined by Anti-Integrin αvβ6 Antibody Predicts Long-Term Clinical Remission of Ulcerative Colitis.

Heterogeneity in semen-mediated tolerogenic responses: defining immunological determinants of reproductive compatibility.

Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty.

Immune checkpoint inhibitors in HIV infection: current evidence on viral reservoir regulation and immune restoration.

Correction: Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty.

Related Experiment Videos

Immune response to influenza vaccination

Related Concept Videos

Related Articles